Product nameAnti-LIP1 antibody
DescriptionRabbit polyclonal to LIP1
Tested applicationsSuitable for: WB, IPmore details
Species reactivityReacts with: Human
Predicted to work with: Chimpanzee, Baboon, Rhesus monkey, Gorilla, Orangutan
Synthetic peptide corresponding to Human LIP1 aa 900-950 (internal sequence).
Database link: NP_443134.2
- HeLa whole cell lysate (ab150035)
This product was previously labelled as STK11IP
Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
Storage bufferPreservative: 0.09% Sodium azide
Constituent: Tris citrate/phosphate
Concentration information loading...
PurityImmunogen affinity purified
Our Abpromise guarantee covers the use of ab90573 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||1/2000 - 1/10000. Predicted molecular weight: 121 kDa.|
|IP||Use at 2-5 µg/mg of lysate.|
FunctionMay regulate STK11 function by controlling its subcellular localization.
Sequence similaritiesBelongs to the STK11IP family.
Contains 8 LRR (leucine-rich) repeats.
Cellular localizationCytoplasm. Some cells show granular or punctuate expression. Colocalizes with STK11 and SMAD4 in granular or punctuate structures.
- Information by UniProt
- KIAA1898 antibody
- LIP1 antibody
- LKB1 interacting protein 1 antibody
All lanes : Anti-LIP1 antibody (ab90573) at 0.4 µg/ml
Lane 1 : HeLa whole cell lysate at 50 µg
Lane 2 : HeLa whole cell lysate at 15 µg
Lane 3 : HeLa whole cell lysate at 5 µg
Developed using the ECL technique.
Predicted band size: 121 kDa
Exposure time: 30 seconds
ab90573 at 1 µg/ml detecting LIP1 following immunoprecipitation.
Lane 1; IP using ab90573
Lane 2; IP using an antibody to an upstream epitope of LIP1
Lane 3; IP using control IgG
All antibodies used at 3 µg/mg lysate. 1 mg of lysate precipitated and 20% loaded.
Developed using the ECL technique with a 30 second exposure.
ab90573 has not yet been referenced specifically in any publications.